Summary. Mouse embryos (4\p=n-\8cells) were cultured for 48 h in vitro in medium containing 1,4,6-androstatriene-3,17-dione (ATD). 
Introduction
The development of a fertilized egg to an implanting blastocyst involves a series of structural and biochemical changes during which cellular differentiation into an inner cell mass and trophoblast occurs. Histochemical evidence of 5-3 ß-hydroxysteroid dehydrogenase (3ß-HSD) and 17ß-hydroxysteroid dehydrogenase (17ß-HSD) in mouse preimplantation embryos suggests that embryos may be able to synthesize steroids; maximum amounts are present just before implantation (S. K. Dey & . Dickmann, unpublished) . The conversion of [3H] testosterone to [3H] oestradiol-17ß is also maximal in rabbit blastocysts at this time (George & Wilson, 1978) .
Steroidogenesis in morulae and blastocysts may play a role in embryonic development and in the preparation of the endometrium for implantation. In the mouse, the development of morulae into blastocysts in vitro was inhibited by citrate, an oestrogen antagonist (Sengupta, Dey & Dickmann, 1977; Roy, 1980) . The present study was undertaken to examine the effect on mouse embryos grown in culture of l,4,6-androstatriene-3,17-dione, an inhibitor of oestrogen synthetase (aromatase) in human placental (Schwarzel, Kruggel & Brodie, 1973) and rat ovarian (Brodie, Schwarzel & Brodie, 1976) Group 6: 4 µg ATD during the second 24 h of the culture period.
In Groups 5 and 6, embryos were recovered after culture for 24 h, washed in fresh medium and briefly examined under a stereo-zoom microscope to check their development, and then re-cultured in fresh medium.
In each group, cultures were repeated several times (see Table 1 ) on several days and the development of expanded blastocysts without any apparent signs of abnormality was taken to indicate normal embryogenesis.
In preliminary experiments 1 µg oestradiol-17 ß/ml was the optimum steroid concentration required to overcome the inhibitory effect of ATD on embryonic development in vitro. ATD at a concentration lower than 4 µg/ml was unable to exert any effect on mouse embryo development.
All results were subjected to a statistical test of proportion (Downie & Heath, 1970) .
Results
The results for Groups 1 and 3 were similar in that oestradiol-17ß overcame the inhibitory influence of ATD (Table 1) . However, addition of oestradiol-17a failed to maintain embryonic development. In Groups 2 and 4 the embryos that did not develop were arrested at the morula stage and showed no signs of degeneration. The treatments for Groups 5 and 6 yielded similar high proportions of developing blastocysts (Table 2) . Barker & Anderson (1968) observed that oestradiol-17a can bind to chromatin of uterine cells, but can not evoke the characteristic responses of hyperaemia and vasodilation normally observed with oestradiol-17 ß. In the present study we found that oestradiol-17a was also unable to mimic the action of oestradiol-17ß on embryonic development.
ATD is an androgenic compound and it could be argued that its deleterious effect on embryos was due to an excessive amount of this steroid. Although ATD has no significant hormonal activity when tested in a conventional bioassay, Christensen & Clemens (1975) noted some androgenic effect in the very sensitive penile spines of the immature rat. In the present study it is unlikely that inhibition is due to any non-specific toxicity or androgenic effect because oestradiol-17ß was effective in nullifying the action of ATD on preimplantation embryos. In rats ATD has an antifertility effect by preventing mating and ovulation and this can be reversed by treatment with exogenous oestrogen (Brodie, Wu, Marsh & Brodie, 1979 
